Memphasys Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Memphasys.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth20.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Memphasys (ASX:MEM) Using Too Much Debt?

Jun 19
Is Memphasys (ASX:MEM) Using Too Much Debt?

Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Mar 01
Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Jun 13
Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Does Memphasys (ASX:MEM) Have A Healthy Balance Sheet?

Jun 20
Does Memphasys (ASX:MEM) Have A Healthy Balance Sheet?

Is Memphasys (ASX:MEM) A Risky Investment?

Feb 28
Is Memphasys (ASX:MEM) A Risky Investment?

Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Sep 01
Memphasys (ASX:MEM) Is Making Moderate Use Of Debt

Will Memphasys (ASX:MEM) Spend Its Cash Wisely?

Jan 07
Will Memphasys (ASX:MEM) Spend Its Cash Wisely?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Memphasys has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:MEM - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241-4-4-3N/A
3/31/20241-4-4-3N/A
12/31/20231-5-4-2N/A
9/30/20231-4-4-2N/A
6/30/20231-3-3-1N/A
3/31/20231-3-3-1N/A
12/31/20221-2-3-1N/A
9/30/20221-2-3-1N/A
6/30/20221-2-30N/A
3/31/20221-2-30N/A
12/31/20211-2-30N/A
9/30/20210-2-30N/A
6/30/20210-1-30N/A
3/31/20210-1-30N/A
12/31/2020N/A-1-30N/A
9/30/2020N/A-1-30N/A
6/30/2020N/A-1-30N/A
3/31/2020N/A-1-30N/A
12/31/2019N/A-1-30N/A
9/30/2019N/A-1-3-1N/A
6/30/2019N/A-1-3-1N/A
3/31/2019N/A-1-3-1N/A
12/31/2018N/A-1-2-1N/A
9/30/2018N/A-1-2-1N/A
6/30/2018N/A0-2-1N/A
3/31/2018N/A-1N/A-1N/A
12/31/2017N/A-1N/A-1N/A
9/30/2017N/A-1N/A-1N/A
6/30/2017N/A-2N/A-1N/A
3/31/20170-2N/A-1N/A
12/31/20160-2N/A-1N/A
9/30/20160-2N/A-1N/A
6/30/20160-2N/A-1N/A
12/31/20150-2N/A-1N/A
9/30/20150-2N/A-2N/A
6/30/20150-2N/A-2N/A
12/31/20140-1N/A-3N/A
9/30/20140-1N/A-3N/A
6/30/20140-1N/A-2N/A
12/31/20131-3N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MEM's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if MEM's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if MEM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MEM's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if MEM's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MEM's Return on Equity is forecast to be high in 3 years time


Discover growth companies